Search API
RECCE® 327 at 4,000 mg intravenously at a fast infusion rate of 20-minutes
May 15, 2024
WPV1 poliovirus eliminated in Malawi and Mozambique
May 14, 2024
51 countries confirm measles outbreaks in 2024
May 14, 2024
Zaire Ebolavirus vaccines and antibody therapies are approved in 2024
May 14, 2024
ACI-24.060 is an anti-Abeta active immunotherapy candidate targeting Alzheimer's disease
May 13, 2024
Protein based COVID-19 vaccine producer Novavax partners with Sanofi
May 10, 2024
Dengue vaccines are approved in May 2024
May 9, 2024
Pika Rabies vaccine candidate targets one-week human rabies regimen
May 9, 2024
Malaria vaccines are unavailable in the United States
May 8, 2024
- 1 of 506
- next ›